Sildenafil for Women: What It Does and When It Is Actually Prescribed

The erectile dysfunction form of sildenafil is not indicated for use by women. That is not a cautious framing or a gap in the research. It appears in the product information as a straightforward statement, and being a woman sits in the list of reasons not to take the medicine at all.

So the short answer to whether women can take sildenafil is no, not that product. Searches for a female sildenafil equivalent are looking for something that does not exist under that licence.

There is one real exception, and it is the reason this page exists rather than being a single line. A separate sildenafil product is licensed for pulmonary arterial hypertension, a serious condition affecting the blood vessels of the lungs. That licence covers adults, and adults includes women. A woman prescribed sildenafil in the UK is almost always being treated for that, under specialist care, with a different product at a different strength.

EveryDayMeds supplies sildenafil for its erectile dysfunction licence in adult men only. We do not supply sildenafil to women, and no consultation route exists for that.

Key things to know

• The erectile dysfunction product is not indicated for use by women. Being a woman is listed among the reasons not to take it
• A separate product is licensed for pulmonary arterial hypertension in adults, which includes women, managed by specialist services
• A trial giving sildenafil to pregnant women was stopped early. In one arm, 17 of 64 babies developed persistent pulmonary hypertension of the newborn, including 11 deaths, against 3 of 58 on placebo
• Sildenafil is not authorised for intrauterine growth restriction, and that MHRA statement followed the trial above
• No sildenafil licence exists for menopause symptoms or for fertility purposes in the UK
• Nitrates and riociguat are contraindicated with sildenafil, whichever product and indication are involved
• Treatment suitability depends on an individual clinical assessment

Can Women Take Sildenafil?

Is It Licensed for Women?

Not in its erectile dysfunction form. The product information states that the medicine is not indicated for use by women, and the patient leaflet lists being a woman among the circumstances in which it should not be taken.

That wording matters. A medicine can be unlicensed for a group simply because nobody studied it there. This is different. The erectile dysfunction licence is for a condition and population for which the product is not indicated in women.

The pulmonary arterial hypertension licence is a genuinely separate authorisation covering a different condition, and it does include adult women. Those two facts sit together without contradiction, because they describe two different products treating two different things.

Is It Safe for Women?

The honest answer is that safety in women has not been established for the erectile dysfunction indication, because it was not studied for that purpose in that population.

Absence of data is not the same as evidence of harm, and it is not the same as reassurance either. What can be said is that the documented safety profile of sildenafil comes from studies in men, and the frequencies quoted for side effects were measured there.

Where women have been given sildenafil in a studied context outside the pulmonary licence, the results have not been encouraging. The trial covered further down is the clearest example, and it is the single most important piece of evidence on this page.

What Would Happen if a Woman Took It?

Sildenafil does not work differently in men and women at the level of the mechanism. It is a phosphodiesterase type 5 inhibitor, which means it prevents the breakdown of a messenger called cyclic guanosine monophosphate, or cGMP, and higher cGMP relaxes the smooth muscle in blood vessel walls.

So the general effects would be expected to occur. Sildenafil has vasodilator properties producing mild and transient decreases in blood pressure, and the documented side effects of the medicine are:

• Headache, very common, affecting more than 1 in 10 people
• Facial flushing and hot flush, common, up to 1 in 10
• Indigestion, nausea and a blocked nose, common
• Dizziness, common
• Visual disturbance, blurred vision and a colour tinge to vision, common
• Fainting, rare, up to 1 in 1,000
• Sudden decrease or loss of vision, or of hearing, rare

Those frequencies were measured in men taking the medicine for its licensed purpose. They should not be assumed to transfer unchanged to a woman taking it outside the licence, which is precisely the problem with using a medicine outside the population it was studied in.

Nitrates and riociguat are contraindicated with sildenafil, while other cardiovascular conditions require individual assessment against the relevant product information. Our guide to what to avoid when taking sildenafil covers these.

The Genuine Reason Women Are Prescribed Sildenafil

Pulmonary Arterial Hypertension

This is the genuine, licensed, everyday reason a woman in the UK is prescribed sildenafil.

Pulmonary arterial hypertension is raised blood pressure in the arteries carrying blood from the heart to the lungs. Those arteries narrow, and the right side of the heart has to work harder. The licensed product for this condition is authorised for adults and for children aged 1 to 17, and adult women are squarely within that.

It works because relaxing the blood vessels of the lungs reduces the resistance the heart pumps against. That is the same cGMP mechanism, applied where the narrowing is the problem.

Treatment is initiated and supervised by specialist services. It involves confirmed diagnosis, disease classification and ongoing monitoring, none of which happens through a remote consultation.

Why That Is Not the Same as the ED Tablets

The two products share an active substance and almost nothing else that matters.

A woman with pulmonary arterial hypertension is not taking the men's tablet. She is taking a different licensed medicine for her own condition, prescribed by the team managing it.

Pulmonary Hypertension in Pregnancy

The pulmonary arterial hypertension product is not recommended in pregnancy unless strictly necessary, and that wording comes from MHRA advice.

Pregnancy with pulmonary arterial hypertension is high risk in its own right and is managed jointly by specialist teams. Any decision about continuing, adjusting or stopping treatment is made with the full individual picture, and nobody should change anything independently.

Start Your Free Assessment

The Mechanism Argument, and Why It Is Not Enough

Sildenafil increases blood flow by relaxing blood vessels, and that effect is not confined to one part of the body. This is the observation that generates almost every theory about using it in women.

It is a reasonable starting point and a poor finishing point. A mechanism that plausibly could help is not the same as a treatment that does help, and the gap between the two is exactly what clinical trials exist to close.

Two things are worth holding onto whenever you see a mechanism argument applied to a new use.

Plausible mechanisms fail routinely. Most medicines with a sound theoretical rationale do not survive testing. That is the normal outcome, not the surprising one.

Testing sometimes reveals harm rather than nothing. The absence of a benefit is the common disappointing result. Discovering that the intervention made things worse is rarer and more serious, and it is what happened in the trial described below.

Where the Evidence Actually Stands

The Regulatory Position

There is no UK licence for sildenafil in women other than pulmonary arterial hypertension. That is the load-bearing fact, and it summarises the position better than any individual study.

A licence exists when a regulator has assessed the evidence and concluded that a medicine works for a stated purpose in a stated population with an acceptable safety profile. The absence of a UK licence means sildenafil has not been authorised for that use here.

We are not summarising individual studies on unlicensed uses on this page. Doing so would mean selectively presenting research on uses we cannot responsibly support, and a page that lists encouraging-looking findings for an unlicensed use is doing marketing rather than information.

Menopause Symptoms

Sildenafil is not licensed in the UK for menopause symptoms, and this page does not support using it for that.

Menopause involves a range of physical changes, and there are established treatment approaches for them. Which is appropriate depends on individual circumstances, symptoms, medical history and preferences, and that is a conversation with a GP or a menopause specialist.

Obtaining erectile dysfunction tablets is not a route to any of that, and a remote assessment designed for a different licensed indication is not a substitute for a proper menopause consultation.

The Endometrial Lining

Sildenafil is not licensed in the UK for any purpose relating to the endometrium, which is the lining of the womb.

The theory behind this search term follows the usual pattern. Sildenafil increases blood flow, blood supply to the womb lining matters, so improving it might help. That is the mechanism argument again, and the same caution applies here as everywhere else.

Fertility treatment is a specialist field with its own regulated services, its own evidence base and its own oversight. Anyone considering anything in that area should be having the conversation within those services, where the full picture including the alternatives can be weighed.

Trying to Conceive, and What a Trial Found

This is where the evidence stops being neutral and becomes a warning, and it deserves the most space on this page.

A clinical trial called STRIDER studied sildenafil given to pregnant women for intrauterine growth restriction, a condition where a baby grows too slowly in the womb. The theory was the familiar one: relaxing blood vessels might improve the blood supply reaching the baby.

The trial was stopped early because of a higher incidence of persistent pulmonary hypertension of the newborn, known as PPHN, and neonatal deaths.

The figures from the Dutch arm are these.

The MHRA advice that followed was direct: sildenafil is not authorised for the treatment of intrauterine growth restriction.

Two conclusions follow, and both matter for anyone reading this page while trying to conceive or while pregnant.

The mechanism argument was tested properly and it failed badly. This was not a case of no benefit. Babies in the sildenafil group experienced more of the condition and more deaths.

Vasodilation in pregnancy is not a neutral intervention. Changing blood flow in a pregnancy affects two circulations, and the consequences were not the ones the theory predicted.

Nothing here supports taking sildenafil while trying to conceive or while pregnant, outside a specialist decision made for pulmonary arterial hypertension with full knowledge of the circumstances.

Side Effects in Women

The side effect profile is not documented separately for women taking the erectile dysfunction product, because that population was not studied for that indication.

What exists is the general profile listed earlier in this page, measured in men. Headache is the only very common effect. Flushing, indigestion, a blocked nose, dizziness and visual changes are common. Fainting and sudden loss of vision or hearing are rare.

There is a specific reason not to assume those numbers transfer. Applying a frequency measured in one group to a different group is exactly the kind of transfer this page refuses to make.

Anyone prescribed sildenafil for pulmonary arterial hypertension will have side effect information relevant to that product from the specialist team, and that is the information to rely on rather than anything derived from the erectile dysfunction studies.

Start Your Free Assessment

How to Judge What You Read About This

Searches on this subject return a large amount of material that is not what it appears to be, and knowing how to sort it is more useful than any single fact on this page.

Three signals are worth checking on anything you read.

Does it have a UK licence? A legitimate page states which product is licensed, for which condition, in which population. A page that describes benefits at length without ever mentioning licensing status is usually avoiding the subject because the answer is inconvenient.

Is it selling something? Products marketed as a female equivalent of an erectile dysfunction medicine appear regularly online, often with the same active ingredient, sometimes under invented brand names. Where those hold no UK licence for the use being advertised, the marketing is running well ahead of the evidence and the regulation.

Where do the numbers come from? Statistics about how many women are affected by a given difficulty, or how many respond to a treatment, should be traceable to a named source and a defined population. Figures that appear without either are usually being repeated rather than checked.

If you are considering buying anything on the strength of what you have read, the practical protection is checking that the supplier holds a GPhC registration and that a prescriber is involved before supply. A supplier willing to sell a prescription medicine for an unlicensed use, to a population it is not licensed for, without an assessment, is not one to rely on.

Sildenafil Alternatives for Women

This page does not list alternatives, and the reason is worth being explicit about rather than leaving as a gap.

Alternatives to sildenafil for women only makes sense as a question if sildenafil were an option for women in the first place. For the erectile dysfunction licence it is not, so there is nothing to find an alternative to.

The routes that make sense are these:

1. A GP appointment, which is the general entry point for a new or unexplained symptom
2. A menopause specialist, where symptoms fit that picture
3. A fertility service, where conception is the concern
4. A pulmonary hypertension specialist service, where that condition is diagnosed or suspected

These concerns generally require appropriate clinical assessment rather than simply obtaining sildenafil online. Your prescriber will determine the appropriate treatment.

What This Page Cannot Do

Being explicit about the limits is part of covering this subject honestly.

• It cannot offer sildenafil to women. The erectile dysfunction product is not indicated for use by women and we do not supply it for that
• It cannot provide a route to the pulmonary arterial hypertension product, which is initiated and supervised by specialist services
• It does not summarise studies on unlicensed uses, because presenting selected findings for uses it cannot support would be marketing rather than information
• It does not give side effect frequencies specific to women, because none exist for this indication
• It does not name alternative products, because the appropriate response depends on a diagnosis this page cannot make

What it does provide is the licensing position stated plainly, the one genuine clinical context in which women are prescribed sildenafil, the safety exclusions that apply to everyone, and the trial evidence that anyone considering this should see before deciding anything.

When to Seek Help Urgently

For anyone taking sildenafil under any licence, seek medical attention immediately for:

• Chest pain
• Fainting or collapse
• Severe or worsening breathlessness
• A sudden decrease or loss of vision, or of hearing
• An allergic reaction

If sildenafil has been taken together with a nitrate or with riociguat, seek urgent medical attention regardless of how you feel.

Anyone who is pregnant and has taken sildenafil should inform their prescriber or maternity team promptly. Suspected side effects can be reported through the MHRA Yellow Card scheme.

Start Your Free Assessment